Selicrelumab (Anti-TNFRSF5 / CD40) | CD markers antibody | Read Reviews & Product Use Citations

Selicrelumab (anti-TNFRSF5 / CD40) is a human immunoglobulin G2 (IgG2) monoclonal antibody agonist of the cell surface receptor CD40 with potential immunostimulatory and antineoplastic activities. It induces changes in the tumor microenvironment and can be used for the research of pancreatic cancer and neoadjuvant tudies. MW: 146.2 kD.

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 6.6mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective CD markers Inhibitors

Biological Activity

Description	Selicrelumab (anti-TNFRSF5 / CD40) is a human immunoglobulin G2 (IgG2) monoclonal antibody agonist of the cell surface receptor CD40 with potential immunostimulatory and antineoplastic activities. It induces changes in the tumor microenvironment and can be used for the research of pancreatic cancer and neoadjuvant tudies. MW: 146.2 kD.

References
[1] Byrne KT, et al. Clin Cancer Res. 2021;27(16):4574-4586.

References

[1] Byrne KT, et al. Clin Cancer Res. 2021;27(16):4574-4586.

Product Details

CAS No.	1622140-49-1
Molecular Weight	146.2
Isotype	Human IgG2SA
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field